Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.
2.

Stereotactic core needle biopsy of nonpalpable breast lesions: initial experience with a promising technique.

Seoudi H, Mortier J, Basile R, Curletti E.

Arch Surg. 1998 Apr;133(4):366-72.

PMID:
9565115
3.

[Results of stereotactic breast biopsy in mammographically suspicious lesions].

Jäger HJ, Schatz TH, Mehring UM, Kubasch M, Hennigs S, Gissler HM, Spörl HD, Mathias KD.

Rofo. 2000 Apr;172(4):346-53. German.

PMID:
10961219
4.

Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme.

Dahlstrom JE, Jain S, Sutton T, Sutton S.

Histopathology. 1996 May;28(5):421-7.

PMID:
8735717
5.

Stereotactic fine needle aspiration in the management of mammographic abnormalities detected in breast screening.

Chan MC, Lam HS, Gwi E, Leung TY, Lau Y, Yip WC.

Aust N Z J Surg. 1996 Sep;66(9):595-7.

PMID:
8859157
6.

Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy.

Mikhail RA, Nathan RC, Weiss M, Tummala RM, Mullangi UR, Lawrence L, Mukkamala A.

Ann Surg Oncol. 1994 Sep;1(5):363-7.

PMID:
7850536
8.

False-negative diagnoses at stereotactic vacuum-assisted needle breast biopsy: long-term follow-up of 1,280 lesions and review of the literature.

Jackman RJ, Marzoni FA Jr, Rosenberg J.

AJR Am J Roentgenol. 2009 Feb;192(2):341-51. doi: 10.2214/AJR.08.1127. Review.

PMID:
19155393
9.

Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.

Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA Jr, Finkelstein SI, Shepard MJ.

Radiology. 1999 Mar;210(3):799-805.

PMID:
10207484
10.
11.

Non-palpable mammographic abnormalities.

Aitken RJ, Chetty U.

J R Coll Surg Edinb. 1991 Dec;36(6):362-71. Review.

PMID:
1774703
12.

Stereotactic core-needle biopsy of non-mass calcifications: outcome and accuracy at long-term follow-up.

Han BK, Choe YH, Ko YH, Nam SJ, Kim JH, Yang JH.

Korean J Radiol. 2003 Oct-Dec;4(4):217-23.

13.

Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.

Johnson JM, Johnson AK, O'Meara ES, Miglioretti DL, Geller BM, Hotaling EN, Herschorn SD.

Radiology. 2015 Apr;275(1):54-60. doi: 10.1148/radiol.14140036. Epub 2014 Nov 25.

14.

Add-on device for stereotactic core-needle breast biopsy: how many biopsy specimens are needed for a reliable diagnosis?

Koskela AK, Sudah M, Berg MH, Kärjä VJ, Mustonen PK, Kataja V, Vanninen RS.

Radiology. 2005 Sep;236(3):801-9. Epub 2005 Jul 14.

PMID:
16020555
15.

Core biopsy for microcalcifications in the breast.

Hirst C, Davis N.

Aust N Z J Surg. 1997 Jun;67(6):320-4.

PMID:
9193263
16.

Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.

Kirshenbaum KJ, Voruganti T, Overbeeke C, Kirshenbaum MD, Patel P, Kaplan G, Maker V, August C, Cavallino RP.

AJR Am J Roentgenol. 2003 Aug;181(2):527-31.

PMID:
12876040
17.
18.

Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.

Fuhrman G, Cederbom G, Champagne J, Farr G, McKinnon W, Bolton J, Ordoyne WK.

J La State Med Soc. 1996 Apr;148(4):167-70.

PMID:
8935619
19.

Role of stereotactic breast biopsy.

Bernstein JR.

Semin Surg Oncol. 1996 Sep-Oct;12(5):290-9. Review.

PMID:
8873316
20.

Supplemental Content

Support Center